TDX ETHOSUXIMIDE— 510(k) K850174

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K850174 for TDX ETHOSUXIMIDE, Substantially Equivalent on 1985-02-06. Applicant: Abbott Laboratories. Device class: 2.

Clearance details

Applicant: Abbott Laboratories
Product code: Code DLF
Device class: Class 2
Regulation: 21 CFR 862.3380
Advisory panel: Clinical Toxicology
Date received: 1985-01-17
Decision date: 1985-02-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Abbott Park, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DLF

K881607 — EASY-TEST EMIT(R) ETHOSUXIMIDE (ETHS) ITEM 166471988-06-01
K844204 — EMIT QST ETHOSUXIMIDE ASSAY1984-12-11
K832797 — MODIFICA- OF EMIT AED ETHOSUXIMIDE ASSAY1983-09-29
K823801 — AMES TDA ETHOSUXIMIDE TEST1983-01-14
K823745 — ADVANCE EMIT-AED ETHOSUXIMIDE1983-01-07

More clearances from Abbott Laboratories

K252424 — Anti-HCV Next2026-04-28
K243500 — ARCHITECT iGentamicin2025-07-09
K243168 — Alinity i Rubella IgG2025-06-20
K243283 — Alinity h-series System2025-02-20
K233932 — Alinity i Toxo IgM2024-08-30

Data sourced from openFDA. This site is unofficial and independent of the FDA.